Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-311,145
Closed -$24.2M 1079
2023
Q4
$24.2M Sell
311,145
-88,888
-22% -$5.5M 0.08% 245
2023
Q3
$22.9M Buy
400,033
+2,749
+0.7% +$143K 0.08% 244
2023
Q2
$20.6M Buy
397,284
+6,330
+2% +$340K 0.07% 286
2023
Q1
$26.3M Sell
390,954
-58
-0% -$4.55K 0.09% 247
2022
Q4
$29.9M Sell
391,012
-8,177
-2% -$608K 0.11% 223
2022
Q3
$32.2M Buy
399,189
+2,456
+0.6% +$233K 0.13% 190
2022
Q2
$35M Sell
396,733
-1,006
-0.3% -$105K 0.13% 184
2022
Q1
$52.9M Sell
397,739
-243
-0.1% -$30.6K 0.15% 162
2021
Q4
$66.8M Buy
397,982
+4,640
+1% +$719K 0.17% 149
2021
Q3
$53.4M Buy
393,342
+59,187
+18% +$7.64M 0.15% 171
2021
Q2
$37.9M Hold
334,155
0.11% 219
2021
Q1
$28.3M Buy
334,155
+5,968
+2% +$499K 0.09% 272
2020
Q4
$25.2M Buy
328,187
+33,739
+11% +$2.28M 0.08% 280
2020
Q3
$18.6M Buy
294,448
+23,733
+9% +$1.29M 0.07% 302
2020
Q2
$13.1M Buy
270,715
+19,676
+8% +$878K 0.05% 367
2020
Q1
$8.83M Sell
251,039
-48,209
-16% -$2.19M 0.04% 387
2019
Q4
$13.9M Sell
299,248
-13,379
-4% -$577K 0.06% 369
2019
Q3
$11.8M Buy
312,627
+1,458
+0.5% +$55.8K 0.05% 423
2019
Q2
$12.5M Buy
311,169
+98,792
+47% +$3.34M 0.05% 415
2019
Q1
$5.84M Buy
212,377
+46,147
+28% +$1.16M 0.02% 603
2018
Q4
$4.01M Buy
166,230
+56,030
+51% +$1.37M 0.02% 665
2018
Q3
$3.14M Buy
+110,200
New +$2.95M 0.01% 788

Other funds holding DAVA

Axa's DAVA Position: Q1 2024 in Review

Axa sold out of Endava (DAVA) in Q1 2024, closing a stake of 311,145 shares — an estimated $24.2M sold.

Axa first reported a position in DAVA in Q3 2018 and held it in 22 quarters. The position peaked at $66.8M in Q4 2021. 196 funds tracked by Wall St. Rank hold DAVA as of Q1 2024.

  • Axa reported no remaining Endava position as of Q1 2024 after selling out during the quarter.
  • Axa sold 311,145 Endava shares in Q1 2024, an estimated $24.2M.
  • Axa first reported a position in Endava in Q3 2018 and held it in 22 quarters.
  • Axa's Endava position peaked at $66.8M in Q4 2021.
  • 196 funds tracked by Wall St. Rank held Endava as of Q1 2024.

Based on Axa's 13F filing for Q1 2024, filed 15 May 2024.